University of Nevada School of Medicine, Laboratory of Cardiac and Vascular Phenomics, USA
Dr. Dayue Darrel Duan, MD, PhD, FAHA, is a Professor of Pharmacology in the Department of Pharmacology and Principle Investigator of the Laboratory of Cardiovascular Phenomics in the Center for Molecular Medicine at School of Medicine, University of Nevada in Reno, Nevada, USA. Dr. Duan discovered several anion channels in the heart and has made significant original contributions to the study of biophysics, physiology, pharmacology, and molecular biology of ion channels in the cardiovascular system. His current research is focusing on the phenomics, functional genomics and proteomics of ion channels in the cardiovascular systems. The Duan laboratory has established several animal models for cardiac diseases and hypertension and has the capacity to study the genome-phenome relationship and molecular mechanisms for cardiovascular disease at multiple levels ranging from whole animal to molecular levels. He delivered over 200 invited lectures and seminars throughout the world, and has published more than 80 peer-reviewed papers and book chapters.
Ion channels, Functional Genomics and Proteomics, Phenomics, Cardiac Electrophysiology and Pharmacology, Cardiac Ischemia, Cardioprotection, Myocardial Hypertrophy and Heart Failure.
Division of Cardiology, Mount Sinai University, USA
Roxana Mehran, MD, is Professor of Medicine at Mount Sinai School of Medicine, Director of Interventional Cardiovascular Research and Clinical Trials at the Zena and Michael A. Wiener Cardiovascular Institute, and Chief Scientific Officer of the Clinical Trial Center at the Cardiovascular Research Foundation. She was previously Associate Professor of Medicine and Director of Outcomes Research, Data Coordination and Analysis at the Center for Interventional Vascular Therapy, Columbia University Medical Center. Dr. Mehran is internationally recognized for her work as a clinical trial specialist with complex data analyses and outcomes research within the field of interventional cardiology. She is also recognized for her experience and expertise in working with regulatory agencies to conduct clinical trials. Her research interests expand from mechanisms of restenosis to treatment and prevention of acute kidney injury in cardiac patients, as well as advancing treatments for acute coronary syndromes and acute myocardial infarction. In addition to founding a highly regarded academic research organization (ARO) within the Cardiovascular Research Foundation, she is also a widely published author in the most respected cardiovascular journals, and has authored and co-authored and co-edited a significant number of books and book chapters. Dr. Mehran has been an invited speaker at national and international scientific conferences such as American Heart Association, American College of Cardiology, European Society of Cardiology, and EuroPCR, and has served as Course Co-Director of the annual Transcatheter Cardiovascular Therapeutics (TCT) for the last 13 years. Dr Mehran completed her training in internal medicine at the University of Connecticut, where she was Chief Medical Resident, before continuing her studies in Cardiovascular Diseases and Interventional Cardiology at Mount Sinai Medical Center in New York. She is an elected fellow of the American College of Cardiology, American College of Physicians, American Heart Association, Society of Cardiac Angiography and Intervention (SCAI), and the European Society of Cardiology. She currently serves on the board of trustees of SCAI, as a member of the Program Committee for the American Heart Association Scientific Sessions, and as Program Chair for SCAIs WIN (Women In Innovations) Initiative.
Acute Coronary Syndrome; cardiac-catheterization ; Coronary Artery Disease; Coronary Stenting; High Blood Pressure; High Cholesterol; Hyperlipidemia